Theravance Bio Ord (TBPH)
9.23 -0.07 (-0.75%) 10:33 ET [NASDAQ]
9.23 x 5 9.26 x 19
Realtime by (Cboe BZX)
9.23 x 5 9.26 x 19
Realtime - - (-) -
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TBPH | ZTS | TAK | SMMT | UTHR |
| Company | Theravance Bio Ord | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Summit Therapeu ADR | United Therapeutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 9.32 | 163.25 | 14.97 | 20.06 | 311.87 |
| High | 9.33 | 164.41 | 15.12 | 20.41 | 318.40 |
| Low | 9.05 | 161.66 | 14.97 | 19.70 | 311.03 |
| Last | 9.23 | 164.13 | 15.11 | 20.40 | 314.47 |
| Change | -0.07 | +1.31 | +0.09 | +0.51 | +3.65 |
| % Change | -0.75% | +0.80% | +0.60% | +2.56% | +1.17% |
| Volume | 39,769 | 219,429 | 218,004 | 407,095 | 18,502 |
| 20-Day Average Volume | 248,597 | 2,499,846 | 1,591,426 | 2,322,023 | 507,030 |
| Previous Close | 9.30 | 162.82 | 15.02 | 19.89 | 310.82 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.36 | 165.09 | 15.01 | 19.58 | 312.84 |
| 20-Day Raw Stochastic | 24.44% | 28.02% | 76.02% | 65.44% | 48.38% |
| 20-Day Relative Strength | 47.83% | 47.26% | 64.17% | 50.23% | 41.31% |
| Weighted Alpha | +1.90 | -6.22 | +12.49 | -2.94 | +17.84 |
| Today's Opinion | 16% Buy | 100% Sell | 88% Buy | 56% Buy | 72% Sell |
| Previous Opinion | 32% Buy | 100% Sell | 88% Buy | 40% Buy | 88% Sell |
| Last Month's Opinion | 32% Buy | 88% Sell | 24% Buy | 32% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.10% since 03/20/25 | +0.62% since 03/20/25 | -0.36% since 03/20/25 | +4.58% since 03/20/25 | -0.14% since 03/20/25 |
| Low | 9.06 on 03/27/25 | 160.25 on 03/25/25 | 14.90 on 03/26/25 | 19.13 on 03/21/25 | 308.43 on 03/21/25 |
| High | 9.55 on 03/21/25 | 165.48 on 03/24/25 | 15.31 on 03/21/25 | 21.70 on 03/26/25 | 322.32 on 03/25/25 |
| 1-Month | |||||
| %Chg | -2.16% since 02/27/25 | -0.49% since 02/27/25 | +5.33% since 02/27/25 | +9.95% since 02/27/25 | -3.24% since 02/27/25 |
| Low | 9.01 on 03/04/25 | 158.30 on 03/14/25 | 14.32 on 02/28/25 | 16.55 on 03/10/25 | 299.47 on 03/13/25 |
| High | 9.91 on 03/07/25 | 177.00 on 03/10/25 | 15.31 on 03/21/25 | 21.70 on 03/26/25 | 324.57 on 03/18/25 |
| 3-Month | |||||
| %Chg | -5.42% since 12/27/24 | -0.26% since 12/27/24 | +13.83% since 12/27/24 | +11.64% since 12/27/24 | -13.00% since 12/27/24 |
| Low | 8.35 on 01/16/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
| High | 10.90 on 01/24/25 | 177.40 on 02/06/25 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 383.51 on 02/19/25 |
| 6-Month | |||||
| %Chg | +11.98% since 09/27/24 | -15.73% since 09/27/24 | +3.89% since 09/27/24 | -2.66% since 09/27/24 | -12.66% since 09/27/24 |
| Low | 7.88 on 10/09/24 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
| High | 10.90 on 01/24/25 | 196.55 on 10/17/24 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 417.82 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 460,080 | 72,909,496 | 47,792,124 | 14,672,455 | 13,959,545 |
| Shares Outstanding, K | 49,471 | 447,792 | 3,181,899 | 737,680 | 44,912 |
| Annual Sales | 64,380,000 | 9,256,000,000 | 29,419,960,000 | 0 | 2,877,400,000 |
| Annual Net Income | -56,420,000 | 2,486,000,000 | 994,060,000 | -221,320,000 | 1,195,100,000 |
| Last Quarter Sales | 18,750,000 | 2,317,000,000 | 7,511,170,000 | 0 | 735,900,000 |
| Last Quarter Net Income | -15,530,000 | 581,000,000 | 156,180,000 | -61,200,000 | 301,300,000 |
| 60-Month Beta | 0.15 | 0.94 | 0.46 | -1.04 | 0.64 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 02/26/25 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | -0.08 on 02/24/25 | 6.19 on 02/26/25 |
| Latest Earnings Date | 05/12/25 | 05/01/25 | 05/08/25 | 05/07/25 | 05/07/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.25 | 10.59 | 0.00 | 12.88 |